{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:41:50Z","timestamp":1791891710672,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":4079,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.7861\/clinmedicine.13-1-63","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T18:27:28Z","timestamp":1361298448000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Pharmacological treatment of chronic stable angina pectoris"],"prefix":"10.1016","volume":"13","author":[{"given":"Jason M","family":"Tarkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.13-1-63_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/clc.4960100314","article-title":"William Heberden and some account of a disorder of the breast","volume":"10","author":"Silverman","year":"1987","journal-title":"Clin Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib2","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1517\/14656566.2011.634799","article-title":"Treatment strategies for chronic stable angina","volume":"12","author":"Kaski","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.7861\/clinmedicine.13-1-63_bib3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction. The American Heart Association\u2019s strategic impact goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.7861\/clinmedicine.13-1-63_bib4","series-title":"Clinical guideline CG126","article-title":"Management of stable angina","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"10.7861\/clinmedicine.13-1-63_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.13-1-63_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"10.7861\/clinmedicine.13-1-63_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/VHRM.S7564","article-title":"Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification and gender disparities","volume":"6","author":"Kones","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.7861\/clinmedicine.13-1-63_bib9","doi-asserted-by":"crossref","first-page":"30E","DOI":"10.1016\/0002-9149(85)91173-7","article-title":"Mixed angina pectoris","volume":"56","author":"Maseri","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.CIR.0000116601.58103.62","article-title":"Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X)","volume":"109","author":"Kaski","year":"2004","journal-title":"Circulation"},{"key":"10.7861\/clinmedicine.13-1-63_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00392-012-0442-4","article-title":"Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X)","volume":"101","author":"Ong","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)","volume":"59","author":"Ong","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00019501-200403000-00007","article-title":"Canadian Cardiovascular Society classification of effort angina: an angiographic correlation","volume":"15","author":"Chockalingam","year":"2004","journal-title":"Coron Artery Dis"},{"key":"10.7861\/clinmedicine.13-1-63_bib15","series-title":"Clinical guideline CG95","article-title":"Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin","author":"National Institute for Health and Clinical Excellence","year":"2010"},{"key":"10.7861\/clinmedicine.13-1-63_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"for the TIBET study group. The total ischaemic burden European trial (TIBET): effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina","volume":"17","author":"Fox","year":"1996","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","article-title":"Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)","volume":"17","author":"Rehnqvist","year":"1996","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib18","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/hc4401.098432","article-title":"Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance","volume":"104","author":"Kim","year":"2001","journal-title":"Circ"},{"key":"10.7861\/clinmedicine.13-1-63_bib19","series-title":"Drugs in cardiology: a comprehensive guide to cardiovascular pharmacotherapy","first-page":"31","article-title":"Chapter 2a: chronic stable angina","author":"Tarkin","year":"2010"},{"issue":"Suppl 3","key":"10.7861\/clinmedicine.13-1-63_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005344-199206203-00013","article-title":"Anti-anginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5 mononitrate and isosorbidedinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients","volume":"20","author":"Doring","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl B","key":"10.7861\/clinmedicine.13-1-63_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/14.suppl_B.30","article-title":"A double-blind comparison of the long term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris","volume":"14","author":"Guermonprez","year":"1993","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","author":"IONA Study Group","year":"2002","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.13-1-63_bib25","series-title":"Drugs in cardiology: a comprehensive guide to cardiovascular pharmacotherapy","year":"2010"},{"key":"10.7861\/clinmedicine.13-1-63_bib26","first-page":"2529","article-title":"Ivabradine: the first selective sinus node If channel inhibitor in the treatment of stable angina","volume":"26","author":"Sulfi","year":"2005","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrcardio.2011.129","article-title":"Stable angina pectoris: antianginal therapies and future directions","volume":"9","author":"Chaitman","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib28","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003495-200767030-00005","article-title":"Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial","volume":"67","author":"Ruzyllo","year":"2007","journal-title":"Drugs"},{"key":"10.7861\/clinmedicine.13-1-63_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"on behalf of the BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.13-1-63_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/11597400-000000000-00000","article-title":"Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study","volume":"12","author":"Majewski","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.7861\/clinmedicine.13-1-63_bib32","first-page":"641","article-title":"Ranolazine: a new approach to treating an old problem","volume":"37","author":"Reddy","year":"2010","journal-title":"Tex Heart Inst J"},{"key":"10.7861\/clinmedicine.13-1-63_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MCA.0b013e32832a198b","article-title":"Ranolazine improves endothelial function in patients with stable coronary artery disease","volume":"20","author":"Deshmukh","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.7861\/clinmedicine.13-1-63_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"for the ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.7861\/clinmedicine.13-1-63_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00019501-200304000-00010","article-title":"Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials","volume":"14","author":"Marzilli","year":"2003","journal-title":"Coron Artery Dis"},{"key":"10.7861\/clinmedicine.13-1-63_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1476-5381.2008.00062.x","article-title":"F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models","volume":"156","author":"Vacher","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.7861\/clinmedicine.13-1-63_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2010.00884.x","article-title":"Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias","volume":"161","author":"Pignier","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.7861\/clinmedicine.13-1-63_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"on behalf of the SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Michael","year":"2010","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.13-1-63_bib44","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.107.763912","article-title":"MERLIN-TIMI 36 Investigators. Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial","volume":"119","author":"Morrow","year":"2009","journal-title":"Circulation"},{"key":"10.7861\/clinmedicine.13-1-63_bib45","first-page":"43","article-title":"Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes","volume":"27","author":"Timmis","year":"2005","journal-title":"Eur Heart J"},{"key":"10.7861\/clinmedicine.13-1-63_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14728210903544482","article-title":"Emerging medical treatment for angina pectoris","volume":"15","author":"Fernandez","year":"2010","journal-title":"Expert Opin Emerging Drugs"},{"issue":"Suppl III","key":"10.7861\/clinmedicine.13-1-63_bib11","first-page":"iii","article-title":"Cardiac syndrome X in women: the role of oestrogen deficiency","volume":"92","author":"Kaski","year":"2006","journal-title":"Heart"},{"key":"10.7861\/clinmedicine.13-1-63_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00878320","article-title":"A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris","volume":"7","author":"Di Somma","year":"1993","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.7861\/clinmedicine.13-1-63_bib22","first-page":"213","article-title":"Comparison of the anti-ischemic and anti-anginal effects of nicorandil and amlodipine in patients with stable angina pectoris: the SWAN study","volume":"2","author":"The SWAN study group","year":"1999","journal-title":"J Clin Basic Cardiol"},{"key":"10.7861\/clinmedicine.13-1-63_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.7861\/clinmedicine.13-1-63_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1476-5381.2010.00912.x","article-title":"15845, a new blocker of the persistent sodium current prevents consequences of hypoxia in rat femoral artery","volume":"161","author":"Bocquet","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824020591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824020591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.13-1-63","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:36:20Z","timestamp":1761460580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824020591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1470211824020591"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.13-1-63","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment of chronic stable angina pectoris","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.13-1-63","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2013. All rights reserved.","name":"copyright","label":"Copyright"}]}}